Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/mus.26896 http://scihub22266oqcxt.onion/10.1002/mus.26896 32311114!7264511!32311114     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Muscle+Nerve 2020 ; 62 (1): 34-40 Nephropedia Template TP {{tp|p=32311114|t=2020. Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic |pdf=|usr=}}{{32311114}} gab.com Text Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic JO: Muscle Nerve http://www.kidney.de/pget.php?&tw=1&pmid=32311114 #FOAvip Since March 2020, the COVID-19 pandemic has led to the need to re-think the delivery of services to patients with chronic dysimmune neuropathies. Telephone/video consultations have become widespread but have compounded concerns about objective evaluation. Therapeutic decisions need, more than ever before, to be considered in the best interests of both patients, and society, while not denying function-preserving/restoring treatment. Immunoglobulin therapy and plasma exchange, for those treated outside of the home, expose patients to the hazards of hospital or outpatient infusion centers. Steroid therapy initiation and continuation pose increased infectious risk. Immunosuppressant therapy similarly becomes highly problematic, with the risks of treatment continuation enhanced by uncertainties regarding duration of the pandemic. The required processes necessitate considerable time and effort especially as resources and staff are re-deployed to face the pandemic, but are essential for protecting this group of patients and as an integral part of wider public health actions. Twit Text FOAVip Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic ????Muscle Nerve http://www.kidney.de/pget.php?&tw=1&pmid=32311114 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32311114 #FOAvip English Wikipedia <ref>{{Cite pmid|32311114}}</ref> Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic #MMPMID32311114 Rajabally YA; Goedee HS; Attarian S; Hartung HP Muscle Nerve 2020[Jul]; 62 (1): 34-40 PMID32311114show ga Since March 2020, the COVID-19 pandemic has led to the need to re-think the delivery of services to patients with chronic dysimmune neuropathies. Telephone/video consultations have become widespread but have compounded concerns about objective evaluation. Therapeutic decisions need, more than ever before, to be considered in the best interests of both patients, and society, while not denying function-preserving/restoring treatment. Immunoglobulin therapy and plasma exchange, for those treated outside of the home, expose patients to the hazards of hospital or outpatient infusion centers. Steroid therapy initiation and continuation pose increased infectious risk. Immunosuppressant therapy similarly becomes highly problematic, with the risks of treatment continuation enhanced by uncertainties regarding duration of the pandemic. The required processes necessitate considerable time and effort especially as resources and staff are re-deployed to face the pandemic, but are essential for protecting this group of patients and as an integral part of wider public health actions. |*Betacoronavirus[MESH] |*Disease Management[MESH] |*Pandemics[MESH] |Autoimmune Diseases of the Nervous System/complications/*therapy[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/epidemiology[MESH] |Humans[MESH] |Pneumonia, Viral/*complications/epidemiology[MESH] |Polyneuropathies/complications/immunology/*therapy[MESH]Management challenges for chronic dysimmune neuropathies during the CO(epmc).pdf DeepDyve Pubget Overpricing